Ensuring timely antibody delivery in the face of supply chain challenges - contact us for solutions

Mouse IgA-UNLB (S107)

Cat. No.:
Purified Mouse IgA for use as a control in flow cytometry assays and as a standard in ELISA.
Size Price (USD) Quantity
1.0 mg $314.00
More Information
Clone S107
Isotype Mouse IgAκ
Specificity C-carbohydrate
Conjugate UNLB (Unconjugated)
Buffer Formulation Borate buffered saline, pH 8.2
Clonality Monoclonal
Concentration 1.0 mg/mL
Volume 1.0 mL
Recommended Storage 2-8°C
Applications Flow Cytometry – Quality tested 18
ELISA – Quality tested 1-17
FLISA – Quality tested
In vivo Control – Reported in literature 19,20

RRID Number AB_2714214

Certificate of Analysis Lookup

Enter the Catalog Number and Lot Number for the Certificate of Analysis you wish to view

Need help with this product?
or call 800.722.2255
  1. 1. Dunn LA, Upcroft JA, Fowler EV, Matthews BS, Upcroft P. Orally administered Giardia duodenalis extracts enhance an antigen-specific antibody response. Infect Immun. 2001;69:6503-10. (ELISA)
  2. 2. Hochepied T, Wullaert A, Berger FG, Baumann H, Brouckaert P, Steidler L, et al. Overexpression of α1-acid glycoprotein in transgenic mice leads to sensitisation to acute colitis. Gut. 2002;51:398-404. (ELISA)
  3. 3. Roopenian DC, Christianson GJ, Sproule TJ, Brown AC, Akilesh S, Jung N, et al. The MHC class I-like IgG receptor controls perinatal IgG transport, IgG homeostasis, and fate of IgG-Fc-coupled drugs. J Immunol. 2003;170:3528-33. (ELISA)
  4. 4. Wang J, Anders RA, Wu Q, Peng D, Cho JH, Sun Y, et al. Dysregulated LIGHT expression on T cells mediates intestinal inflammation and contributes to IgA nephropathy. J Clin Invest. 2004;113:826-35. (ELISA)
  5. 5. Chen C, Louie S, Shi HN, Walker WA. Preinoculation with the probiotic Lactobacillus acidophilus early in life effectively inhibits murine Citrobacter rodentium colitis. Pediatr Res. 2005;58:1185-91. (ELISA)
  6. 6. Genestier L, Taillardet M, Mondiere P, Gheit H, Bella C, Defrance T. TLR agonists selectively promote terminal plasma cell differentiation of B cell subsets specialized in thymus-independent responses. J Immunol. 2007;178:7779-86. (ELISA)
  7. 7. Arnaboldi PM, Roth-Walter F, Mayer L. Suppression of Th1 and Th17, but not Th2, responses in a CD8+ T cell-mediated model of oral tolerance. Mucosal Immunol. 2009;2:427-38. (ELISA)
  8. 8. Patterson HC, Kraus M, Wang D, Shahsafaei A, Henderson JM, Seagal J, et al. Cytoplasmic Igα serine/threonines fine-tune Ig α tyrosine phosphorylation and limit bone marrow plasma cell formation. J Immunol. 2011;187:2853-8. (ELISA)
  9. 9. Generoso SV, Viana ML, Santos RG, Arantes RM, Martins FS, Nicoli JR, et al. Protection against increased intestinal permeability and bacterial translocation induced by intestinal obstruction in mice treated with viable and heat-killed Saccharomyces boulardii. Eur J Nutr. 2011;50:261-9. (ELISA)
  10. 10. Batista MA, Nicoli JR, Martins Fdos S, Machado JA, Arantes RM, Quirino IE, et al. Pretreatment with citrulline improves gut barrier after intestinal obstruction in mice. JPEN J Parenter Enteral Nutr. 2012;36:69-76. (ELISA)
  11. 11. Chapman JR, Barral P, Vannier J, Borel V, Steger M, Tomas-Loba A, et al. RIF1 is essential for 53BP1-dependent nonhomologous end joining and suppression of DNA double-strand break resection. Mol Cell. 2013;49:858-71. (ELISA)
  12. 12. Steinberg RS, Silva LC, Souza TC, Lima MT, de Oliveira NL, Vieira LQ, et al. Safety and protective effectiveness of two strains of Lactobacillus with probiotic features in an experimental model of salmonellosis. Int J Environ Res Public Health. 2014;11:8755-76. (ELISA)
  13. 13. Mann JF, McKay PF, Fiserova A, Klein K, Cope A, Rogers P, et al. Enhanced immunogenicity of an HIV-1 DNA vaccine delivered with electroporation via combined intramuscular and intradermal routes. J Virol. 2014;88:6959-69. (ELISA)
  14. 14. Alsadeq A, Hobeika E, Medgyesi D, Kläsener K, Reth M. The role of the Syk/Shp-1 kinase-phosphatase equilibrium in B cell development and signaling. J Immunol. 2014;193:268-76. (ELISA)
  15. 15. Goverse G, Olivier BJ, Molenaar R, Knippenberg M, Greuter M, Konijn T, et al. Vitamin A metabolism and mucosal immune function are distinct between BALB/c and C57BL/6 mice. Eur J Immunol. 2015;45:89-100. (ELISA)
  16. 16. Vogelzang A, McGuire HM, Liu SM, Gloss B, Mercado K, Earls P, et al. IL-21 contributes to fatal inflammatory disease in the absence of Foxp3+ T regulatory cells. J Immunol. 2014;192:1404-14 (ELISA)
  17. 17. Santos RG, Quirino IE, Viana ML, Generoso SV, Nicoli JR, Martins FS, et al. Effects of nitric oxide synthase inhibition on glutamine action in a bacterial translocation model. Br J Nutr. 2014;111:93-100. (ELISA)
  18. 18. Benhamron S, Tirosh B. Direct activation of mTOR in B lymphocytes confers impairment in B-cell maturation and loss of marginal zone B cells. Eur J Immunol. 2011;41:2390-6. (FC)
  19. 19. Quesada AJ, Nelius T, Yap R, Zaichuk TA, Alfranca A, Filleur S, et al. In vivo upregulation of CD95 and CD95L causes synergistic inhibition of angiogenesis by TSP1 peptide and metronomic doxorubicin treatment. Cell Death Differ. 2005;12:649-58. (In vivo control)
  20. 20. Seibert CW, Rahmat S, Krause JC, Eggink D, Albrecht RA, Goff PH, et al. Recombinant IgA is sufficient to prevent influenza virus transmission in guinea pigs. J Virol. 2013;87:7793-804. (In vivo control)
See All References